generics
Leading pharmaceutical companies sued in US for conspiring to drive up generics prices
June 11, 2020Business Services drugs, generics, lawsuit, price fixing, price-fixing
26 pharmaceutical companies are being sued by most US states for allegedly conspiring to reduce competition and drive up generic …
Trump signs deal with generics company Phlow Corp to help shift drug manufacturing to the US
May 19, 2020Manufacturing and Production APIs, COVID-19, Drugs manufacturing, coronavirus, generics
The Trump administration will sign a $354 million deal with the generics company Phlow Corp to help produce medicines and …
How the intended role of generic medicines is being undermined in America
April 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, US, feature, generic medicines, generics
The introduction of a generic medicine should, in theory, incentivise companies to lower the price of the original drug, creating healthy …
Novartis’ subsidiary Sandoz agrees to pay $195 million to settle antitrust case
March 3, 2020Manufacturing and Production Novartis, US Courts, generic drugs, generics, price fixing, price-fixing
Novartis’ Sandoz will pay a $195 million criminal penalty to resolve charges that it conspired to price-fix, rig bids and …
FDA approves first generic version of Shkreli-hiked toxoplasmosis drug Daraprim
March 2, 2020Sales and Marketing Cerovene, Daraprim, FDA, Martin Shkreli, generics, pharma
The FDA has awarded approval to the first generic medicine for the treatment of toxoplasmosis, authorising Cerovene’s version of Daraprim …
FDA approves first three generic versions of Novartis’ Gilenya for relapsing multiple sclerosis
December 6, 2019Medical Communications, Sales and Marketing Novartis, generics, gilenya, multiple sclerosis, pharma
The FDA has approved the first three generic versions of Novartis’ sphingosine 1-phosphate receptor modulator Gilenya (fingolimod) to treat adult …
Pfizer to combine off-patent drug unit Upjohn with Mylan
July 30, 2019Manufacturing and Production M&A, MA, Mylan, Pfizer, Upjohn, biosimilars, generics, mergers
Pfizer’s off-patent drug unit Upjohn is combining with Mylan to create a new global pharmaceutical company focused on the low-price …
Prices hiked on 3,400 drugs in first half of 2019
July 4, 2019Research and Development, Sales and Marketing abstruse, access, generics, pharma, prescription, pricing
There have been price hikes on more than 3,400 drugs in the United States in the first six months of …
Read the July/August edition of Pharmafocus online now!
June 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Orkambi, Trump, UK, brexit, generics, manufacturing compliance, pharma
The latest monthly edition of Pharmafocus, the July/August issue, is available to read for free online now!The UK remains split …
China urges firms to make generic versions of 34 drugs
June 25, 2019Research and Development China, NHC, generic drugs, generics, patents, pharma
China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …
EU pharmaceutical industry lost €16.5 billion in sales as staff shift to patent infringing firms
June 19, 2019Research and Development EU, counterfeit, generics, pharma, sales
A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 …
FDA expand Paragraph IV Patent Certifications List for generic drugmakers
June 19, 2019Research and Development FDA, Hatch-Waxman act, generic drugs, generics, pharma
The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …
Sandoz is first multinational to secure generic approval under new Chinese guidelines
May 20, 2019Sales and Marketing China, Novartis, Sandoz, generics, pharma, rosuvastatin
Sandoz has revealed that its generic statin rosuvastatin, known in its branded incarnation as Crestor, has been given approval in …
Top Ten most popular articles on Pharmafile.com this week!
May 17, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Gilead, J&J, JJ, Janssen, Mundipharma, Novartis, Teva, generics
Some big names – including Gilead, Janssen, Teva and Bristol-Myers Squibb – were in trouble this week after two separate …
US States allege 20 generic drugmakers fixed prices of generic drugs
May 13, 2019Sales and Marketing competition, generics, markets, price fixing, price-fixing, pricing
Forty-four US States have filed a lawsuit against 20 generic drugmakers – including Teva Pharmaceuticals – over allegations the firms …
